Xcellerex and Itero Biopharmaceuticals have entered into a strategic collaboration for the production of Itero’s lead product, an undisclosed therapeutic protein. Xcellerex will provide development and product manufacturing for global clinical and commercialization supplies. The two companies anticipate that this will be a multi-product collaboration. For the first product, Xcellerex will manufacture Itero’s Phase III clinical materials in 2010/2011. “Xcellerex is enabling Itero’s rapid drug ...